Navigation Links
Future Role of Market Research Made Clear in New Report from Best Practices, LLC
Date:5/12/2010

CHAPEL HILL, N.C., May 12 /PRNewswire/ -- Leading organizations understand the value of using market research to inform their strategic planning and operational tactics across numerous functions. As pharmaceutical, biotechnology and medical device companies evolve, market research in these companies must also evolve and develop new capabilities while refining current ones to support intelligent planning and decision making.

Two areas where market research leaders anticipate providing more support in the future are new product development and strategic planning, according to new research from Best Practices, LLC. "The Future of Market Research: Challenges and Changes in a Core Pharmaceutical Function" provides executives and managers working in the market research/business intelligence area with forward-looking insights around critical market research topics.

To view a summary of this report, download a complimentary excerpt at http://www3.best-in-class.com/rr998.htm.

This study provides data on activities, roles, talent development, and effectiveness measures around the market research function. The research also identifies recent changes, new directions and best practices in market research that will enable the market research function to continue to provide value.

Among the topics addressed in this report are:

  • Market Research Roles & Responsibilities
  • Use of Outside Resources
  • Market Research Talent Selection & Development
  • Metrics & Performance

Data for this study were collected utilizing primary research via an online survey that drew 42 representatives from 35 companies in the pharmaceutical, biotechnology and medical device sectors. In addition, six interviews were conducted with selected participants. Study participants included Abbott, Bayer, Boehringer Ingelheim, Alcon, EMD Serono, GlaxoSmithKline, Merck, Johnson & Johnson, Novo Nordisk, Pfizer, Vertex, Ortho-McNeil and Wyeth.

Among the key findings in this report are:

  • Currently, New Product Development and Strategic Planning responsibilities are split between Market Research and other organizations. A strong refocusing on development and planning suggests Market Research's vital role in strategic decision support. 

  • More than two-thirds of respondents believe Market Research will balance strategic and tactical work in three to five years. Few believe tactical market research will be the main focus of the function in three to five years.

To learn more about this report, download a complimentary excerpt at http://www3.best-in-class.com/rr998.htm. For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC 

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 46 out of the top 50 pharmaceutical companies. For more information, call 919-403-0251 or visit http://www3.best-in-class.com/.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Is there a micro-supercapacitor in your future?
2. Reportlinker Adds Future of Red Biotechnology in China
3. Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders
4. Gloabl Harvest Initiative: Taking Down Fences To Meet Future Needs
5. New graphene nanomesh could change the future of electronics
6. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
7. Single-step technique produces both p-type and n-type doping for future graphene devices
8. What's Next for Stevia? Experts from GLG Life Tech Corp Share Views on Stevia's Future at Complimentary Webinar on 17 Feb.
9. InfoSpi Shall Benefit From Contract for Future Use of IBS Technology
10. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
11. Nanowires key to future transistors, electronics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... will be hosting a Webinar titled, “Pathology is going digital. Is your lab ... digital pathology adoption best practices and how Proscia improves lab economics and realizes ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):